Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-10
2006-10-10
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S039000
Reexamination Certificate
active
07119100
ABSTRACT:
The present invention relates to oripavine derivatives of formula (I),wherein R1is hydrogen or methyl, R2is methyl, cyclopropyl methyl, cyclobutyl methyl or allyl, R3is thiophenyl ethyl or cycloalkyl methyl where the cycloalkyl has 3 to 6 carbon atoms, or non-toxic pharmaceutically acceptable salts thereof. These compounds can be used for the preparation of analgesics or abstinence agents of opium habit-forming drugs.
REFERENCES:
patent: 3433791 (1969-03-01), Bentley
patent: 3442900 (1969-05-01), Bentley
patent: 3474101 (1969-10-01), Bentley
patent: 5849915 (1998-12-01), Kim et al.
Huang, Comparison of pharmacological Activities of Buprenorphine and Norbuprenorphine: Norbuprenorphine is a Potent Opiod Agonist, J. Pharmacology and Experimental Therapeutics, 297(2), (2001), 688-695.
Gong Zehui
Liu Yongshao
Wang Yaping
Zhong Bohua
Institute of Pharmacology and Toxicology Academy of Military Med
Owens Amelia A.
Zhejiang Xianju Pharmaceuticals Co. Ltd.
LandOfFree
Oripavine derivatives and their uses as pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oripavine derivatives and their uses as pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oripavine derivatives and their uses as pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3716060